Logo image of BSN

BROADSTONE ACQUISITION COR-A (BSN) Stock Fundamental Analysis

USA - NYSE:BSN - Common Stock

10.68
+1.71 (+19.06%)
Last: 12/15/2021, 8:17:43 PM
10.68
0 (0%)
After Hours: 12/15/2021, 8:17:43 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BSN. BSN was compared to 0 industry peers in the Unkown industry. The financial health of BSN is average, but there are quite some concerns on its profitability. BSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BSN had negative earnings in the past year.
BSN Yearly Net Income VS EBIT VS OCF VS FCFBSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 -100K -200K -300K

1.2 Ratios

Industry RankSector Rank
ROA -0.94%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BSN Yearly ROA, ROE, ROICBSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 -0.02 -0.04 -0.06 -0.08

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSN Yearly Profit, Operating, Gross MarginsBSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020

More info and screens

5

2. Health

2.1 Basic Checks

BSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BSN Yearly Shares OutstandingBSN Yearly Shares OutstandingYearly Shares Outstanding 2020 10M 20M 30M
BSN Yearly Total Debt VS Total AssetsBSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 100M 200M 300M

2.2 Solvency

An Altman-Z score of 6.08 indicates that BSN is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.08
ROIC/WACCN/A
WACCN/A
BSN Yearly LT Debt VS Equity VS FCFBSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.28 indicates that BSN may have some problems paying its short term obligations.
A Quick Ratio of 0.28 indicates that BSN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
BSN Yearly Current Assets VS Current LiabilitesBSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4546.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BSN Price Earnings VS Forward Price EarningsBSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSN Per share dataBSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROADSTONE ACQUISITION COR-A

NYSE:BSN (12/15/2021, 8:17:43 PM)

After market: 10.68 0 (0%)

10.68

+1.71 (+19.06%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.21%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap407.58M
Revenue(TTM)N/A
Net Income(TTM)-2.89M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.01
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z 6.08
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4546.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BROADSTONE ACQUISITION COR-A / BSN FAQ

What is the fundamental rating for BSN stock?

ChartMill assigns a fundamental rating of 1 / 10 to BSN.


What is the valuation status of BROADSTONE ACQUISITION COR-A (BSN) stock?

ChartMill assigns a valuation rating of 1 / 10 to BROADSTONE ACQUISITION COR-A (BSN). This can be considered as Overvalued.


How profitable is BROADSTONE ACQUISITION COR-A (BSN) stock?

BROADSTONE ACQUISITION COR-A (BSN) has a profitability rating of 1 / 10.